Kanawha Capital Management LLC decreased its position in MetLife, Inc. (NYSE:MET – Free Report) by 1.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,202 shares of the financial services provider’s stock after selling 1,160 shares during the quarter. Kanawha Capital Management LLC’s holdings in MetLife were worth $4,883,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Robeco Institutional Asset Management B.V. grew its holdings in shares of MetLife by 18.6% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 186,361 shares of the financial services provider’s stock valued at $15,371,000 after acquiring an additional 29,163 shares in the last quarter. Carmichael Hill & Associates Inc. boosted its position in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Janney Capital Management LLC grew its stake in MetLife by 1.9% in the third quarter. Janney Capital Management LLC now owns 40,390 shares of the financial services provider’s stock valued at $3,331,000 after purchasing an additional 740 shares in the last quarter. F M Investments LLC increased its position in shares of MetLife by 17.9% during the 3rd quarter. F M Investments LLC now owns 98,418 shares of the financial services provider’s stock worth $8,105,000 after purchasing an additional 14,976 shares during the last quarter. Finally, Chicago Partners Investment Group LLC acquired a new position in shares of MetLife during the 3rd quarter worth approximately $233,000. Institutional investors own 89.81% of the company’s stock.
MetLife Trading Up 0.0 %
Shares of MetLife stock opened at $78.43 on Monday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.16 and a current ratio of 0.16. The firm has a 50-day moving average of $80.59 and a 200-day moving average of $74.92. MetLife, Inc. has a 52-week low of $58.89 and a 52-week high of $86.94. The stock has a market cap of $54.93 billion, a PE ratio of 15.81, a PEG ratio of 0.66 and a beta of 1.05.
MetLife Dividend Announcement
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. Citigroup lifted their price objective on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. TD Cowen initiated coverage on MetLife in a report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Barclays dropped their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday. Piper Sandler raised their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Jefferies Financial Group boosted their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $88.38.
View Our Latest Stock Report on MET
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- What Investors Need to Know to Beat the Market
- Bright Future for Clean Hydrogen Stocks? Analysts Are Watching
- What is a Death Cross in Stocks?
- High-Yield AbbVie Gains Momentum: A 20% Upside Is in Sight
- How to Use High Beta Stocks to Maximize Your Investing Profits
- How to Play New Options Trading With Bitcoin ETFs
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.